COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL
The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceu...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PATEL, Manit RADDA, Rusinova JADHAV, Vishal Anant GHOVANLOO, Mohammad-Reza FOUDA, Mohamed Amin CHOUDHURY, Koushik PHATERPEKAR, Tejas RUBEN, Peter Charles DR.PAGE, Dana A |
| description | The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.
L'invention concerne diverses compositions pharmaceutiques comprenant le nouvel agent thérapeutique cannabidiol qui intervient en faveur des canaux sodiques affectés négativement Nav1.5 et sert ainsi d'agent thérapeutique potentiel pour traiter divers troubles cardiaques. L'invention concerne également diverses compositions pharmaceutiques utilisant le nouvel agent thérapeutique cannabidiol pour supprimer ou réduire au minimum les effets secondaires d'autres agents thérapeutiques/médicaments qui induisent, ou qui sont susceptibles d'induire un QT long. L'invention concerne en outre une composition pharmaceutique de cannabidiol destinée à traiter ou à prévenir une inflammation induite par n'importe quel autre agent thérapeutique ou une inflammation induite par n'importe quelles maladies ou affections telles que la Covid-19, mais également une inflammation induite par n'importe quel vaccin, tel que le vaccin contre la Covid-19. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021165992A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021165992A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021165992A13</originalsourceid><addsrcrecordid>eNrjZDBw9vcN8A_2DPH09wtWcPRzUQjxcA1yDHANDfF0VggNdg1W8HdTcHb083N08nTx9PfhYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkaGhmamlpZGjobGxKkCANW3J1I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><source>esp@cenet</source><creator>PATEL, Manit ; RADDA, Rusinova ; JADHAV, Vishal Anant ; GHOVANLOO, Mohammad-Reza ; FOUDA, Mohamed Amin ; CHOUDHURY, Koushik ; PHATERPEKAR, Tejas ; RUBEN, Peter Charles ; DR.PAGE, Dana A</creator><creatorcontrib>PATEL, Manit ; RADDA, Rusinova ; JADHAV, Vishal Anant ; GHOVANLOO, Mohammad-Reza ; FOUDA, Mohamed Amin ; CHOUDHURY, Koushik ; PHATERPEKAR, Tejas ; RUBEN, Peter Charles ; DR.PAGE, Dana A</creatorcontrib><description>The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.
L'invention concerne diverses compositions pharmaceutiques comprenant le nouvel agent thérapeutique cannabidiol qui intervient en faveur des canaux sodiques affectés négativement Nav1.5 et sert ainsi d'agent thérapeutique potentiel pour traiter divers troubles cardiaques. L'invention concerne également diverses compositions pharmaceutiques utilisant le nouvel agent thérapeutique cannabidiol pour supprimer ou réduire au minimum les effets secondaires d'autres agents thérapeutiques/médicaments qui induisent, ou qui sont susceptibles d'induire un QT long. L'invention concerne en outre une composition pharmaceutique de cannabidiol destinée à traiter ou à prévenir une inflammation induite par n'importe quel autre agent thérapeutique ou une inflammation induite par n'importe quelles maladies ou affections telles que la Covid-19, mais également une inflammation induite par n'importe quel vaccin, tel que le vaccin contre la Covid-19.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210826&DB=EPODOC&CC=WO&NR=2021165992A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210826&DB=EPODOC&CC=WO&NR=2021165992A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PATEL, Manit</creatorcontrib><creatorcontrib>RADDA, Rusinova</creatorcontrib><creatorcontrib>JADHAV, Vishal Anant</creatorcontrib><creatorcontrib>GHOVANLOO, Mohammad-Reza</creatorcontrib><creatorcontrib>FOUDA, Mohamed Amin</creatorcontrib><creatorcontrib>CHOUDHURY, Koushik</creatorcontrib><creatorcontrib>PHATERPEKAR, Tejas</creatorcontrib><creatorcontrib>RUBEN, Peter Charles</creatorcontrib><creatorcontrib>DR.PAGE, Dana A</creatorcontrib><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><description>The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.
L'invention concerne diverses compositions pharmaceutiques comprenant le nouvel agent thérapeutique cannabidiol qui intervient en faveur des canaux sodiques affectés négativement Nav1.5 et sert ainsi d'agent thérapeutique potentiel pour traiter divers troubles cardiaques. L'invention concerne également diverses compositions pharmaceutiques utilisant le nouvel agent thérapeutique cannabidiol pour supprimer ou réduire au minimum les effets secondaires d'autres agents thérapeutiques/médicaments qui induisent, ou qui sont susceptibles d'induire un QT long. L'invention concerne en outre une composition pharmaceutique de cannabidiol destinée à traiter ou à prévenir une inflammation induite par n'importe quel autre agent thérapeutique ou une inflammation induite par n'importe quelles maladies ou affections telles que la Covid-19, mais également une inflammation induite par n'importe quel vaccin, tel que le vaccin contre la Covid-19.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9vcN8A_2DPH09wtWcPRzUQjxcA1yDHANDfF0VggNdg1W8HdTcHb083N08nTx9PfhYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkaGhmamlpZGjobGxKkCANW3J1I</recordid><startdate>20210826</startdate><enddate>20210826</enddate><creator>PATEL, Manit</creator><creator>RADDA, Rusinova</creator><creator>JADHAV, Vishal Anant</creator><creator>GHOVANLOO, Mohammad-Reza</creator><creator>FOUDA, Mohamed Amin</creator><creator>CHOUDHURY, Koushik</creator><creator>PHATERPEKAR, Tejas</creator><creator>RUBEN, Peter Charles</creator><creator>DR.PAGE, Dana A</creator><scope>EVB</scope></search><sort><creationdate>20210826</creationdate><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><author>PATEL, Manit ; RADDA, Rusinova ; JADHAV, Vishal Anant ; GHOVANLOO, Mohammad-Reza ; FOUDA, Mohamed Amin ; CHOUDHURY, Koushik ; PHATERPEKAR, Tejas ; RUBEN, Peter Charles ; DR.PAGE, Dana A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021165992A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PATEL, Manit</creatorcontrib><creatorcontrib>RADDA, Rusinova</creatorcontrib><creatorcontrib>JADHAV, Vishal Anant</creatorcontrib><creatorcontrib>GHOVANLOO, Mohammad-Reza</creatorcontrib><creatorcontrib>FOUDA, Mohamed Amin</creatorcontrib><creatorcontrib>CHOUDHURY, Koushik</creatorcontrib><creatorcontrib>PHATERPEKAR, Tejas</creatorcontrib><creatorcontrib>RUBEN, Peter Charles</creatorcontrib><creatorcontrib>DR.PAGE, Dana A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PATEL, Manit</au><au>RADDA, Rusinova</au><au>JADHAV, Vishal Anant</au><au>GHOVANLOO, Mohammad-Reza</au><au>FOUDA, Mohamed Amin</au><au>CHOUDHURY, Koushik</au><au>PHATERPEKAR, Tejas</au><au>RUBEN, Peter Charles</au><au>DR.PAGE, Dana A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><date>2021-08-26</date><risdate>2021</risdate><abstract>The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.
L'invention concerne diverses compositions pharmaceutiques comprenant le nouvel agent thérapeutique cannabidiol qui intervient en faveur des canaux sodiques affectés négativement Nav1.5 et sert ainsi d'agent thérapeutique potentiel pour traiter divers troubles cardiaques. L'invention concerne également diverses compositions pharmaceutiques utilisant le nouvel agent thérapeutique cannabidiol pour supprimer ou réduire au minimum les effets secondaires d'autres agents thérapeutiques/médicaments qui induisent, ou qui sont susceptibles d'induire un QT long. L'invention concerne en outre une composition pharmaceutique de cannabidiol destinée à traiter ou à prévenir une inflammation induite par n'importe quel autre agent thérapeutique ou une inflammation induite par n'importe quelles maladies ou affections telles que la Covid-19, mais également une inflammation induite par n'importe quel vaccin, tel que le vaccin contre la Covid-19.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021165992A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T10%3A59%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PATEL,%20Manit&rft.date=2021-08-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021165992A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |